Genetics and Genomics of Leukaemia
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Genetics".
Deadline for manuscript submissions: 23 July 2024 | Viewed by 519
Special Issue Editors
Interests: chromosome biology with particular focus on cancer and leukaemia
Special Issues, Collections and Topics in MDPI journals
Interests: chromosome biology and the transcriptomics of rare leukaemia subtypes, through the development of in vitro models; 2D–3D cell cultures, gene editing (CRISPR/Cas9), molecular cytogenetic methods, and the bioinformatics of omics data
Special Issue Information
Dear Colleagues,
This Special Issue on the genetics and genomics of leukaemia aims to provide a comprehensive platform on the latest advancements and insights into the genetic and genomic bases of leukaemia. By bringing together diverse perspectives and research findings, this Special Issue seeks to enhance our understanding of the genetic as well as genomic landscapes of leukaemia and foster the development of precision medicine approaches for this challenging disease. Researchers, clinicians, and experts in the field are encouraged to contribute their valuable insights to advance our knowledge and improve patient outcomes in leukaemia.
This Special Issue invites original research articles, reviews, and communications encompassing a wide range of topics, including, but not limited to, the following:
- Molecular profiling of leukaemia subtypes and their genetic drivers.
- Identification and characterization of genetic mutations, chromosomal rearrangements, and copy number variations associated with different leukaemia types.
- Functional genomics and pathway analyses to elucidate the molecular mechanisms underlying leukaemia development and progression.
- Genomic instability and its impact on leukaemia evolution and treatment resistance.
- Role of epigenetic modifications in leukaemogenesis and their potential as therapeutic targets.
- Applications of next-generation sequencing, single-cell genomics, and other cutting-edge technologies in leukaemia research.
- Genomic biomarkers for the risk stratification, treatment selection, and monitoring of leukaemia patients.
Dr. Sabrina Tosi
Dr. Denise Ragusa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- leukaemia
- blood
- genetics
- genomics
- chromosome
